National & Regional Partnerships
Finding a cure for cancer in our lifetime!
Cancer is a community disease
Chances are, you know someone with cancer. There are over 20 million people living with cancer in the world today. About 1,332,100 more people will be diagnosed with cancer this year in the United States alone.
- 77% of new cancers will be diagnosed in people over age 55.
- In the United States, a man’s risk of developing cancer is slightly less than 1 in 2.
- A U.S. woman’s risk is slightly more than 1 in 3.
- About 5% to 10% of cancers are hereditary.
- Childhood cancers account for less than 1% of all cancers diagnosed in the United States.
National and Regional Partners
Oregon Clinical and Translational Research Institute (OCTRI)
The Oregon Clinical and Translational Research Institute (OCTRI) will fundamentally change biomedical research to create a vibrant academic home for clinical/translational investigation. It will leverage existing strengths and remove barriers to the pace and growth of research. At the heart of the OCTRI is a robust partnership between Oregon Health & Science University and Kaiser Permanente's Center for Health Research that brings together a strong biomedical research university and an innovative practice-based research center associated with a large patient population. The collaboration provides unique opportunities for expansion across the spectrum of human investigation, and sets the stage for major advances in human health.Read more.
Lance Armstrong Foundation/Young Adult Alliance (YAA)
OHSU’s Adolescent and Young Adult Oncology program was founded with support from the Lance Armstrong Foundation. The Lance Armstrong Foundation unites people to fight cancer, believing unity is strength, knowledge is power and attitude is everything. Our Adolescent and Young Adult oncology program is a charter member of the LIVESTRONG Young Adult Alliance. Read more.
American Cancer Society
The OHSU Knight Cancer Institute and the American Cancer Society partner in many ways to bring additional services to our cancer patients. Read more
Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society’s research grants program currently supports more than 400 grants in over 14 countries. This includes $1.5 million in funds in Oregon and Southwest Washington. The Society supports chronic myeloid leukemia research by the director of the OHSU Knight Cancer Institute, Dr. Brian Druker, who developed the medication Gleevec. His laboratory continues to research new treatments for chronic myeloid leukemia. Read more
Kaiser Permanente Northwest: Oregon Evidence-based Practice Center
The Oregon Evidence-based Practice Center (EPC) is a collaboration of Oregon Health & Science University, the Portland Veterans Affairs Medical Center, and the Kaiser Permanente Center for Health Research. The Oregon EPC was founded in 1997 with funding from the U.S. Agency for Healthcare Research and Quality . It was reauthorized as an EPC in 2002 and 2007. Read more
Komen for the Cure
De La Salle North Catholic School
The OHSU Knight Cancer Institute partners with De La Salle North Catholic School by allowing individual students to work one full day each week in our Radiation Medicine and Center for Hematologic Malignancies departments. By working in job sharing teams, theses students fill full-time entry level jobs in these departments while being exposed to real life healthcare environments. Academic schedules are structured so that students are available to work without missing class and we believe this experience may encourage future careers in the health sciences. Students assign their earnings to De La Salle North Catholic High School to pay for 70% of the cost of their education. Students receive a college preparatory education they previously could not afford while gaining valuable job experience. More
Oregon State Cancer Registry
The OHSU Knight Cancer Institute Cancer Registry submits data monthly to the Oregon State Cancer Registry (OSCaR). In turn, OSCaR sends data to the National Program of Cancer Registries, part of the U.S. Centers for Disease Control. In addition, data are submitted annually to the American College of Surgeons Commission on Cancer , the National Cancer Data Base and the Federal Information Processing System (FIPS), which releases Level II data to the American Cancer Society. The Cancer Registry maintains a wide range of demographic, diagnostic, treatment and outcomes data on all patients with a cancer diagnosis, as well as all primary brain and central nervous system tumors, benign and malignant. The data are used in many ways, including evaluation of treatment modalities, analysis of patient outcomes and routine submission to state and national databases. Read more
